Most Read News

This QIP permits them to raise capital by issuing new shares to institutional investors such as banks and mutual funds.

The NFO is available for subscription from September 17 to September 24.

IPO proceeds will be used to fund ₹120 Crore for working capital, ₹30 Crore for acquisitions to support inorganic growth, and general corporate purposes.

ABCL’s consolidation aims to improve operational efficiency, simplify processes, and enhance capital allocation across subsidiaries, benefiting shareholders.

According to the draft papers, the corporation will only issue new shares, and current shareholders will not sell their stakes.

Zee stated that the arbitration is still in its early stages, and the LCIA Arbitral Tribunal has yet to determine whether the corporation is culpable in any way.

Anchor investors, including SBI General Insurance, Kotak Mahindra Life, and Goldman Sachs, invested ₹229 Crore prior to the IPO.

On June 17, 2022, Aurobindo purchased a 51% share in GLS Pharma from entrepreneur Suresh Pathak and his family members.

Joglekar's experience includes working at Strategic Capital Corporation Private Limited, which broadened his financial knowledge significantly.

Share allotment is expected to be finalized on September 19, and listing on the BSE and NSE is set for September 23.